Viking Therapeutics VKTX Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

PfizerPFE

$222.4B+9.2%

AmgenAMGN

$252.17B+23.1%

Gyre Therapeutics, Inc.GYRE

$694.84M+6.1%

Madrigal Pharmaceuticals, Inc.MDGL

$12.46B+98.7%

VAN

Vivani MedicalVANI

$83.88M+9.2%

FAQ

What is Viking Therapeutics's enterprise value?

Viking Therapeutics (VKTX) reported enterprise value of $3.81B in Q4 2025.

How has Viking Therapeutics's enterprise value changed year-over-year?

Viking Therapeutics's enterprise value decreased by 14.5% year-over-year, from $4.46B to $3.81B.

What is the long-term trend for Viking Therapeutics's enterprise value?

Over 5 years (2020 to 2025), Viking Therapeutics's enterprise value has grown at a 56.1% compound annual growth rate (CAGR), from $411.7M to $3.81B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.